SEC Form 4 · accession 0000899243-17-010898
APPLIED GENETIC TECHNOLOGIES CORP · AGTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arnold L Oronsky
Director
Period of report
Apr 24, 2017
Accepted (ET)
Apr 26, 2017 · 1:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001273636
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| CommonF1,F4 | Apr 24, 2017 | X | 3,559 | — | A | 1,404,515 | I | By Partnership |
| CommonF2,F5 | Apr 24, 2017 | X | 101 | — | A | 40,181 | I | By Partnership |
| CommonF3,F6 | Apr 24, 2017 | X | 28 | — | A | 11,208 | I | By Partnership |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant to buy CommonF4 | $4.5395 | Apr 24, 2017 | X | 11,476 | D | May 2, 2012 | May 2, 2017 | Common | 11,476 | 0 | I |
| Warrant to buy CommonF5 | $4.5395 | Apr 24, 2017 | X | 328 | D | May 2, 2012 | May 2, 2017 | Common | 328 | 0 | I |
| Warrant to buy CommonF6 | $4.5395 | Apr 24, 2017 | X | 91 | D | May 2, 2012 | May 2, 2017 | Common | 91 | 0 | I |
Explanation of responses
- F1Represents cashless exercise of a warrant by InterWest Partners VIII, LP ("IW8"). 7,917 shares of common stock were withheld by the issuer at the market price of $6.58 per share to fund the cashless exercise of 11,476 warrants.
- F2Represents cashless exercise of a warrant by InterWest Investors Q VIII, LP ("IIQ8"). 227 shares of common stock were withheld by the issuer at the market price of $6.58 per share to fund the cashless exercise of 328 warrants.
- F3Represents cashless exercise of a warrant by InterWest Investors VIII, LP ("II8"). 63 shares of common stock were withheld by the issuer at the market price of $6.58 per share to fund the cashless exercise of 91 warrants.
- F4Shares are owned by IW8. The General Partner of IW8 is InterWest Management Partners VIII, LLC ("IMP8"). The Reporting Person is a Managing Director of IMP8, shares voting and investment power with the other Managing Directors of IMP8, and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- F5Shares are owned by IIQ8. The General Partner of IW8 is IMP8. The Reporting Person is a Managing Director of IMP8, shares voting and investment power with the other Managing Directors of IMP8, and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- F6Shares are owned by II8. The General Partner of IW8 is IMP8. The Reporting Person is a Managing Director of IMP8, shares voting and investment power with the other Managing Directors of IMP8, and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.